In a usual twist, Roussel-Uclaf did eventually release the drug after government pressure. I found this to be the most interesting and complex decision of the entire book. From a quick glance, the decision and the outcome appear to be simple. The company did not want to take a stand on a controversial issue, but would not hand over a patent for someone else to make money off of their hard work. However, the set-up and timing of the decision makes the scenario more complex. The company never really chose a side and appeared to remain neutral throughout the entire process. First, in terms of the initial decision, the company never stated that it was morally wrong to produce the drug or that they did not plan to release it in the future. They simply stated it was causing division within the company and they did not know how profitable it would really be. Second, the vote occurred during the meeting of the World Congress of Gynecology and Obstetrics. These are the professionals that will be seriously affected by the decisions, so it’s no surprise that RU486 became a major discussion topic. This led to many members signing a petition to make Roussel-Uclaf release the drug. Finally, when the government threatened to take the company’s patent away, Roussel-Uclaf decided to release the drug. This allowed the decision to appear purely based on business. Even if some stakeholders disagree morally, they would prefer to capitalize on the drug than give it away for someone else to produce. I really enjoyed the metaphor of the lion and the wolf. Sakiz definitely took a stealthy approach when dealing with this complex situation. In the end, no one really lost. The drug was released and Roussel-Uclaf did not take a stand on the controversial
In a usual twist, Roussel-Uclaf did eventually release the drug after government pressure. I found this to be the most interesting and complex decision of the entire book. From a quick glance, the decision and the outcome appear to be simple. The company did not want to take a stand on a controversial issue, but would not hand over a patent for someone else to make money off of their hard work. However, the set-up and timing of the decision makes the scenario more complex. The company never really chose a side and appeared to remain neutral throughout the entire process. First, in terms of the initial decision, the company never stated that it was morally wrong to produce the drug or that they did not plan to release it in the future. They simply stated it was causing division within the company and they did not know how profitable it would really be. Second, the vote occurred during the meeting of the World Congress of Gynecology and Obstetrics. These are the professionals that will be seriously affected by the decisions, so it’s no surprise that RU486 became a major discussion topic. This led to many members signing a petition to make Roussel-Uclaf release the drug. Finally, when the government threatened to take the company’s patent away, Roussel-Uclaf decided to release the drug. This allowed the decision to appear purely based on business. Even if some stakeholders disagree morally, they would prefer to capitalize on the drug than give it away for someone else to produce. I really enjoyed the metaphor of the lion and the wolf. Sakiz definitely took a stealthy approach when dealing with this complex situation. In the end, no one really lost. The drug was released and Roussel-Uclaf did not take a stand on the controversial